Pure Global AI
NCT06346886Not yet recruiting

HTN App for HTN Control and Cardiovascular Health Among African-Americans

FAITH! Hypertension App to Improve Hypertension Control and Cardiovascular Health Among African-Americans: A Decentralized Randomized Clinical Trial
Mayo ClinicClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Hypertension
Drug/Device/Intervention
FAITH! HTN app
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Mayo Clinic
Location
Rochester, United States of America
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2024
End date
Jul 01, 2025
Enrollment
100 participants
Primary outcome

Absolute Change in Systolic Blood Pressure (BP),HTN Self-Care as reported by H-SCALE(HTN Self-Care Activity Level Effects)

Summary

The purpose of this study is to test the hypertension (HTN) app-based intervention to see if
 it is more effective in improving uncontrolled HTN and HTN self-care among Africian-Americans
 from baseline to post-intervention (immediate, 3 months and 6 months post-intervention) as
 compared to the standard of care.

ICD-10 classifications
Hypertensive diseasesRenovascular hypertensionSecondary hypertensionOther secondary hypertensionHypertensive heart disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06346886
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06346886 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.